Levocar

Carbidopa/Levodopa, the active ingredient in Levocar, is a Antiparkinson agent presented as an oral tablet for oral use. It is indicated for the management of Parkinson's disease and Parkinsonian syndrome, helping to restore deficient dopamine activity in the central nervous system. The combination improves motor function and reduces rigidity and tremor in affected patients.

GNH USA supplies Levocar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance.

Levocar (carbidopa/levodopa) is used in the dopaminergic pathway to manage Parkinsonian disorders.

- Parkinson's disease: improves motor symptoms, functional ability and quality of life. - Parkinsonian syndrome: alleviates rigidity, tremor, and bradykinesia associated with secondary causes. - Levodopa‑responsive dystonia: provides symptomatic relief by increasing central dopamine levels.

Levocar may cause a range of adverse reactions, which are grouped by frequency and severity.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Dizziness: sensation of light‑headedness, especially on standing. - Orthostatic hypotension: drop in blood pressure upon standing. - Headache: mild to moderate cranial pain. - Insomnia: difficulty initiating or maintaining sleep. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Dyskinesia: involuntary, erratic movements. - Psychosis: hallucinations or delusional thinking. - Severe hypotension: marked blood‑pressure fall requiring medical attention. - Cardiac arrhythmia: irregular heart rhythm. - Neuroleptic malignant syndrome: life‑threatening reaction with fever and rigidity. - Anaphylaxis: acute allergic reaction with airway compromise.

Before initiating Levocar, clinicians should consider several safety measures.

- Dose titration: start low and increase gradually to minimize gastrointestinal and cardiovascular side effects. - Renal impairment: adjust dose or monitor closely in patients with reduced kidney function. - Hepatic impairment: use with caution and monitor liver enzymes. - Concomitant MAO‑B inhibitors: avoid use within 14 days to prevent hypertensive crises. - Pregnancy and lactation: prescribe only if the potential benefit outweighs the potential risk to the fetus or infant. - Store at ambient temperature: keep below 25 °C, protect from moisture and light, and retain in the original packaging.

Levocar can interact with several drug classes, requiring attention to avoid reduced efficacy or heightened toxicity.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: may precipitate hypertensive crisis. - Antipsychotics (dopamine antagonists): can diminish therapeutic effect. - Antihypertensive agents: may cause excessive hypotension.

Moderate Interactions (Monitor Closely): - SSRIs and SNRIs: increased risk of serotonin syndrome. - Iron or calcium supplements: reduce levodopa absorption; separate dosing by at least 2 hours.